Daratumumab Improves Progression-Free Survival for Patients with Multiple Myeloma
A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for ...
Read more »A summary of clinical trial results showing that daratumumab plus lenalidomide and dexamethasone improved progression-free survival for ...
Read more »Plasma cell neoplasms (including multiple myeloma ) treatment include observation, chemotherapy, radiation, stem cell rescue, targeted,...
Read more »